Deborah Slipetz
Impact in
- Pharmacology top 0.5%
- Inflammatory mediators and NSAID effects
- Cannabis and Cannabinoid Research
- Biochemistry top 2%
- Eicosanoids and Hypertension Pharmacology
Papers in
- Pharmacology 10
- Inflammatory mediators and NSAID effects 6
- Cannabis and Cannabinoid Research 3
-
- Allergic Rhinitis and Sensitization 3
- Co-authors
- Kathleen M. MettersMark AbramovitzYves BoieNicole SawyerThomas H. RushmoreRyszard GrygorczykGary P. O’NeillRino Stocco
- Journals
- Bioorganic & Medicinal Chemistry Letters (7 papers)Journal of Biological Chemistry (5 papers)European Journal of Pharmacology (3 papers)American Journal of Respiratory Cell and Molecular Biology (3 papers)Molecular Pharmacology (2 papers)
- Partner nations
- CanadaUnited StatesJapan
In The Last Decade
Deborah Slipetz
27 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 103
- Pharmacology 921
- Biochemistry 244
- Cellular and Molecular Neuroscience 439
- Physiology 464
- Toxicology 54
Countries citing papers authored by Deborah Slipetz
This map shows the geographic impact of Deborah Slipetz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Slipetz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Slipetz more than expected).
Fields of papers citing papers by Deborah Slipetz
This network shows the impact of papers produced by Deborah Slipetz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Slipetz. The network helps show where Deborah Slipetz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Deborah Slipetz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 11 | |
| 2 | 2010 | 39 | |
| 3 | 2010 | 19 | |
| 4 | 2010 | 46 | |
| 5 | 2010 | 1 | |
| 6 | 2009 | 20 | |
| 7 | 2008 | 31 | |
| 8 | 2006 | 34 | |
| 9 | 2006 | 79 | |
| 10 | 2005 | 43 | |
| 11 | 2004 | 65 | |
| 12 | 2003 | 68 | |
| 13 | 2003 | 21 | |
| 14 | 2002 | 37 | |
| 15 | 1999 | 21 | |
| 16 | 1997 | 259 | |
| 17 | 1995 | 286 | |
| 18 | 1995 | 27 | |
| 19 | 1994 | 168 | |
| 20 | 1993 | 22 |
About Deborah Slipetz
Deborah Slipetz is a scholar working on Pharmacology, Immunology and Allergy, Physiology, Microbiology and Toxicology, having authored 28 papers that have together received 2.1k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (9 papers), Inflammatory mediators and NSAID effects (6 papers), Asthma and respiratory diseases (6 papers), Allergic Rhinitis and Sensitization (3 papers), Cannabis and Cannabinoid Research (3 papers), Neuropeptides and Animal Physiology (3 papers), Chemical Synthesis and Analysis (2 papers) and Atomic and Subatomic Physics Research (2 papers). The work is most often cited by research in Pharmacology (921 citations), Biochemistry (244 citations), Cellular and Molecular Neuroscience (439 citations), Physiology (464 citations) and Toxicology (54 citations). Deborah Slipetz has collaborated with scholars based in Canada, United States and Japan. Frequent co-authors include Kathleen M. Metters, Mark Abramovitz, Yves Boie, Nicole Sawyer, Thomas H. Rushmore, Ryszard Grygorczyk, Gary P. O’Neill, Rino Stocco, Tuan Nguyen and M A Bayne. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Biological Chemistry, European Journal of Pharmacology, American Journal of Respiratory Cell and Molecular Biology and Molecular Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.